ProPhase Labs, Inc. Deferred Tax Assets, Property, Plant and Equipment
ProPhase Labs, Inc. (PRPH) had Deferred Tax Assets, Property, Plant and Equipment of $497.00 thousand as of 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment · last filed 2026-06-01
- 2025-12-31: Deferred Tax Assets, Property, Plant and Equipment $497.00K.
- 2024-12-31: Deferred Tax Assets, Property, Plant and Equipment $783.00K.
- 2022-12-31: Deferred Tax Assets, Property, Plant and Equipment $705.00K.
- 2021-12-31: Deferred Tax Assets, Property, Plant and Equipment $948.00K.
| Period end | Deferred Tax Assets, Property, Plant and Equipment | Deferred Tax Assets, Property, Plant and Equipment as first filed |
|---|---|---|
| 2025-12-31 | $497.00K 10-K · filed 2026-06-01 | |
| 2024-12-31 | $783.00K 10-K · filed 2026-06-01 | |
| 2022-12-31 | $705.00K 10-K · filed 2023-03-29 | |
| 2021-12-31 | $948.00K 10-K · filed 2023-03-29 | |
| 2020-12-31 | $419.00K 10-K · filed 2022-03-31 | |
| 2019-12-31 | $93.00K 10-K · filed 2021-03-31 | |
| 2018-12-31 | $109.00K 10-K · filed 2020-03-26 | -$109.00K 10-K · filed 2019-03-26 |
| 2017-12-31 | $41.00K 10-K · filed 2019-03-26 | $52.00K 10-K · filed 2018-03-28 |
| 2016-12-31 | -$304.00K 10-K/A · filed 2018-08-20 | |
| 2015-12-31 | -$103.00K 10-K/A · filed 2018-08-20 | |
| 2014-12-31 | -$45.00K 10-K · filed 2017-02-24 | |
| 2013-12-31 | -$34.00K 10-K · filed 2016-03-29 | |
| 2012-12-31 | $60.00K 10-K · filed 2015-03-27 | |
| 2011-12-31 | $235.00K 10-K · filed 2014-03-27 | |
| 2010-12-31 | $253.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |